Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yven Van Herrewege

In Vitro Evaluation of Nonnucleoside Reverse Transcriptase Inhibitors UC-781 and TMC120-R147681 as Human Immunodeficiency Virus Microbicides

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2004

English

Human Immunodeficiency Virus Type 1 (HIV-1) Integration: A Potential Target for Microbicides to Prevent Cell-Free or Cell-Associated HIV-1 Infection

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2008

English

Related publications

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2011

English

Human Immunodeficiency Virus Reverse Transcriptase Substrate-Induced Conformational Changes and the Mechanism of Inhibition by Nonnucleoside Inhibitors.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1995

English

Comprehensive Mutant Enzyme and Viral Variant Assessment of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistance to Nonnucleoside Inhibitors.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1993

English

In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 Against NNRTI-Resistant Human Immunodeficiency Virus Type 1

English

Human Immunodeficiency Virus-1 Reverse Transcriptase Heterodimer Stability

English

Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2008

English

Human Immunodeficiency Virus Reverse Transcriptase Displays Dramatically Higher Fidelity Under Physiological Magnesium Conditions in Vitro

English

DeNovoParallel Design, Synthesis and Evaluation of Inhibitors Against the Reverse Transcriptase of Human Immunodeficiency Virus Type-1 and Drug-Resistant Variants.

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2007

English

Studies of Neutralizing Monoclonal Antibody to Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Antagonistic and Synergistic Effects in Reactions Performed in the Presence of Nucleoside and Nonnucleoside Inhibitors, Respectively.

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yven Van Herrewege

In Vitro Evaluation of Nonnucleoside Reverse Transcriptase Inhibitors UC-781 and TMC120-R147681 as Human Immunodeficiency Virus Microbicides

Human Immunodeficiency Virus Type 1 (HIV-1) Integration: A Potential Target for Microbicides to Prevent Cell-Free or Cell-Associated HIV-1 Infection

Related publications

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides

Human Immunodeficiency Virus Reverse Transcriptase Substrate-Induced Conformational Changes and the Mechanism of Inhibition by Nonnucleoside Inhibitors.

Comprehensive Mutant Enzyme and Viral Variant Assessment of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistance to Nonnucleoside Inhibitors.

In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 Against NNRTI-Resistant Human Immunodeficiency Virus Type 1

Human Immunodeficiency Virus-1 Reverse Transcriptase Heterodimer Stability

Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor

Human Immunodeficiency Virus Reverse Transcriptase Displays Dramatically Higher Fidelity Under Physiological Magnesium Conditions in Vitro

DeNovoParallel Design, Synthesis and Evaluation of Inhibitors Against the Reverse Transcriptase of Human Immunodeficiency Virus Type-1 and Drug-Resistant Variants.

Studies of Neutralizing Monoclonal Antibody to Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Antagonistic and Synergistic Effects in Reactions Performed in the Presence of Nucleoside and Nonnucleoside Inhibitors, Respectively.